Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

The communication of pharmacogenetic research results: participants weigh in on their informational needs in a pilot study.

Madadi P, Joly Y, Avard D, Chitayat DC, Smith MA, D Ross CJ, Carleton BC, Hayden MR, Koren G.

J Popul Ther Clin Pharmacol. 2011;18:e152-5. Epub 2011 Mar 21.

PMID:
21467605
2.

Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefits.

Madadi P, Joly Y, Avard D, Chitayat DC, Smith MA, Ross CJ, Carleton BC, Hayden MR, Koren G.

Clin Pharmacol Ther. 2010 Dec;88(6):792-5. doi: 10.1038/clpt.2010.125. Epub 2010 Aug 25.

PMID:
20739920
3.

Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study.

Madadi P, Ross CJ, Hayden MR, Carleton BC, Gaedigk A, Leeder JS, Koren G.

Clin Pharmacol Ther. 2009 Jan;85(1):31-5. doi: 10.1038/clpt.2008.157. Epub 2008 Aug 20.

PMID:
18719619
4.

Ethical considerations in CYP2D6 genotype testing for codeine-prescribed breastfeeding mothers.

Kurtz M, Black Golde P, Berlinger N.

Clin Pharmacol Ther. 2010 Dec;88(6):760-2. doi: 10.1038/clpt.2010.225. Review.

PMID:
21081947
5.

Genetic transmission of cytochrome P450 2D6 (CYP2D6) ultrarapid metabolism: implications for breastfeeding women taking codeine.

Madadi P, Ciszkowski C, Gaedigk A, Leeder JS, Teitelbaum R, Chitayat D, Koren G.

Curr Drug Saf. 2011 Feb 1;6(1):36-9.

PMID:
21241245
6.

Re: Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer [corrected].

de Wildt SN, Koren G.

Paediatr Anaesth. 2008 Mar;18(3):273-4; author's reply 275-6. doi: 10.1111/j.1460-9592.2008.02418.x. No abstract available. Erratum in: Paediatr Anaesth. 2008 May;18(5):454.

PMID:
18230076
7.

Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother.

Koren G, Cairns J, Chitayat D, Gaedigk A, Leeder SJ.

Lancet. 2006 Aug 19;368(9536):704. No abstract available.

PMID:
16920476
8.

The pharmacogenetics of codeine hypoalgesia.

Sindrup SH, Brøsen K.

Pharmacogenetics. 1995 Dec;5(6):335-46. Review.

PMID:
8845855
9.

Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers.

Sistonen J, Madadi P, Ross CJ, Yazdanpanah M, Lee JW, Landsmeer ML, Nauta M, Carleton BC, Koren G, Hayden MR.

Clin Pharmacol Ther. 2012 Apr;91(4):692-9. doi: 10.1038/clpt.2011.280. Epub 2012 Mar 7.

PMID:
22398969
10.

Clinical perspective on the Clinical Pharmacogenetics Implementation Consortium Updated 2014 guidelines for CYP2D6 and codeine.

Nicholson WT, Formea CM.

Clin Chem. 2015 Feb;61(2):319-21. doi: 10.1373/clinchem.2014.226795. Epub 2014 Oct 9. No abstract available.

11.

CYP2D6 genotyping and codeine.

de Leon J.

Paediatr Anaesth. 2008 Mar;18(3):274-5; author reply 275-6. doi: 10.1111/j.1460-9592.2008.02420.x. No abstract available.

PMID:
18230077
12.

Elucidation of CYP2D6 genetic diversity in a unique African population: implications for the future application of pharmacogenetics in the Xhosa population.

Wright GE, Niehaus DJ, Drögemöller BI, Koen L, Gaedigk A, Warnich L.

Ann Hum Genet. 2010 Jul;74(4):340-50. doi: 10.1111/j.1469-1809.2010.00585.x.

13.

Codeine metabolism in three Oriental populations: a pilot study in Chinese, Japanese and Koreans.

Yue QY, Svensson JO, Säwe J, Bertilsson L.

Pharmacogenetics. 1995 Jun;5(3):173-7. No abstract available.

PMID:
7550369
14.

Pain management of musculoskeletal injuries in children: current state and future directions.

Ali S, Drendel AL, Kircher J, Beno S.

Pediatr Emerg Care. 2010 Jul;26(7):518-24; quiz 525-8. doi: 10.1097/PEC.0b013e3181e5c02b. Review.

PMID:
20622635
15.

Risk to the breast-fed neonate from codeine treatment to the mother: a quantitative mechanistic modeling study.

Willmann S, Edginton AN, Coboeken K, Ahr G, Lippert J.

Clin Pharmacol Ther. 2009 Dec;86(6):634-43. doi: 10.1038/clpt.2009.151. Epub 2009 Aug 26.

PMID:
19710640
16.

Pharmacogenetic screening and therapeutic drugs.

Steimer W, Potter JM.

Clin Chim Acta. 2002 Jan;315(1-2):137-55. Review.

PMID:
11728416
17.

Cytochrome P450 2D6 and treatment of codeine dependence.

Romach MK, Otton SV, Somer G, Tyndale RF, Sellers EM.

J Clin Psychopharmacol. 2000 Feb;20(1):43-5.

PMID:
10653207
18.

A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk.

Kelly LE, Chaudhry SA, Rieder MJ, 't Jong G, Moretti ME, Lausman A, Ross C, Berger H, Carleton B, Hayden MR, Madadi P, Koren G.

PLoS One. 2013 Jul 29;8(7):e70073. doi: 10.1371/journal.pone.0070073. Print 2013.

19.

Is pharmacogenetic CYP2D6 testing useful?

Vetti HH, Molven A, Eliassen AK, Steen VM.

Tidsskr Nor Laegeforen. 2010 Nov 18;130(22):2224-8. doi: 10.4045/tidsskr.09.1445. English, Norwegian.

20.

Supplemental Content

Support Center